# The Human Medicines (Amendment etc.) (EU Exit) (No. 2) Regulations 2021, Regulation 9: Amendment of regulation 58 (consideration of application)


In regulation 58, after paragraph (4C) insert—
“(4D) When considering an application for a UK marketing authorisation, the licensing authority may, if it considers appropriate, grant a UKMA(UK), UKMA(GB) or UKMA(NI), regardless of the indication given under regulation 49(9).”

---
Source: https://www.legislation.gov.uk/ukdsi/2021/9780348228755/regulation/9 (the official version)
Page: https://openlegislation.uk/draft-human-medicines-amendment-etc-eu-exit-no-2-regulations-2021/regulation-9
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.